Trials / Unknown
UnknownNCT00181012
Benefit of Lidocaine Perfusion in Cancer Related Visceral Pain Resistant to Morphinics
Benefit of Lidocaine Perfusion in Cancer Related Visceral Pain Resistant to Morphinics: Efficacy Study in Adults and Children. Randomized Prospective Study With Direct Individual Benefit
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris · Academic / Other
- Sex
- All
- Age
- 6 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This study will evaluate the benefit of lidocaine perfusion in cancer related visceral pain resistant to morphinics. It is an efficacy study in adults and children and a randomized prospective study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lidocaine |
Timeline
- Start date
- 2005-05-01
- First posted
- 2005-09-16
- Last updated
- 2007-09-19
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT00181012. Inclusion in this directory is not an endorsement.